VEGFA and neoplasm: Despite the moderate so far success of anti-angiogenic therapy, and while VEGF mainly targets endothelial cells, it has been demonstrated that this factor has multiple effects on additional cell types, including immune and tumor cells [13,15,16]; thus, implicating VEGF in diverse molecular pathogenic processes that drive tumor progression, unrelated to the stimulation of angiogenesis [5].